Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for secondary packaging, labelling, testing/quality control of batch and batch release)

The drug is used to treat various types of cancer, including metastatic colorectal cancer, cancer of the stomach, pancreas, esophagus, as well as breast cancer and squamous cell carcinoma of the head and neck.

Dosage form: solution for injection

ATC: L01BC02